Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit [0.03%]
代谢紊乱人群脂蛋白(a)水平升高及其与动脉粥样硬化性心血管疾病相关性的流行病学研究：来自血脂专病门诊的真实世界数据
Francesco Di Giacomo Barbagallo,Ana González-Lleó,Núria Amigo et al.
Francesco Di Giacomo Barbagallo et al.
Background and aims: Lipoprotein(a) (Lp(a)) is a proatherogenic particle that is considered an important cardiovascular risk modifier due to its association with atherosclerotic cardiovascular disease (ASCVD) as well as c...
Atherogenic Risk in Commerce and Industry Workers: Associations with Sociodemographic and Lifestyle Factors in a Large Spanish Occupational Cohort [0.03%]
商业和工业从业人员的致动脉粥样硬化风险：大型西班牙职业队列中社会人口学和生活方式因素的相关性分析
María Pilar Fernández-Figares Vicioso,María Teófila Vicente-Herrero,Pere Riutord Sbert et al.
María Pilar Fernández-Figares Vicioso et al.
Background: Atherogenic dyslipidemia (AD) and associated lipid ratios are critical markers for cardiovascular risk, yet little is known about how these markers vary by occupational sector and sociodemographic or lifestyle...
Importance of cardiovascular and atherogenic risk in healthcare professionals [0.03%]
医疗专业人员的心血管和动脉硬化风险的重要性
Johanna Vicuña
Johanna Vicuña
Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study [0.03%]
CORDIOPREV研究中短端粒作为2型糖尿病标志的风险
Ana Ojeda-Rodriguez,Maria Jose Parraga-Viudez,Juan L Romero-Cabrera et al.
Ana Ojeda-Rodriguez et al.
Background: The presence of type 2 diabetes mellitus (T2DM) in cardiovascular disease (CVD) is associated with poorer clinical outcomes. To identify biomarkers is essential to predict T2DM onset and progression in the con...
Comparative performance of machine learning vs classical formulas for LDL-cholesterol calculation [0.03%]
机器学习与经典公式计算低密度脂蛋白胆固醇的比较性能分析
Salomón Martín Pérez,Remo Suppi,Teresa Arrobas Velilla et al.
Salomón Martín Pérez et al.
Introduction: Low-density lipoprotein cholesterol (LDL-C) is a significant cardiovascular risk factor, as direct measurement is expensive and often unavailable in most clinical laboratories. The Friedewald formula (FD), d...
Telomere length is associated with arterial damage in the CORDIOPREV study [0.03%]
端粒长度与CORDIOPREV研究中的动脉损伤有关
Ana Ojeda-Rodriguez,Maria Jose Parraga-Viudez,Alejandro López-Moreno et al.
Ana Ojeda-Rodriguez et al.
Background: Telomere length (TL) has emerged as a recognized biomarker of biological aging and cardiovascular risk. Several studies have associated short TL with increased incidence of cardiovascular disease and adverse o...
The usefulness of studying visceral fat for early stratification of atherogenic risk: from conventional anthropometry to more accurate measurements [0.03%]
关于早期分层动脉粥样硬化风险的内脏脂肪研究的有用性：从传统体质测量到更准确的测量方法
Francisco Martín Luján,Rosa Solà Alberich
Francisco Martín Luján
Atherogenic risk in normal-weight workers: Associations with sociodemographic and healthy lifestyle factors using lipid-based indexes [0.03%]
正常体重员工的致动脉粥样硬化风险：基于血脂指标与社会人口统计学和健康生活方式因素之间的关联性分析
Claudia Isabella Tirado Cabrera,Daniel Guzmán Capote,Pedro Juan Tárraga López et al.
Claudia Isabella Tirado Cabrera et al.
Background: Atherogenic dyslipidemia is a significant but often underrecognized cardiovascular risk factor in individuals with normal weight. Traditional metrics such as body mass index (BMI) may fail to identify metaboli...
Relationship between apolipoprotein(a) isoforms and lipoprotein(a) levels in patients with acute coronary syndrome [0.03%]
急性冠脉综合征患者载脂蛋白（a）同型变异体与脂蛋白（a）水平的关系
Rosa Fernández-Olmo,Jesús Lara Mariscal,Ana García Ruano et al.
Rosa Fernández-Olmo et al.
Lp(a) is a cardiovascular risk factor influenced by the LPA gene and apo(a) isoforms. Their relationship is not always linear and there are discordant phenotypes, for this reason in our work we evaluated the association between apo(a) isofo...
Real-world characterization of clinical management and achievement of the recommended risk-based low-density lipoprotein cholesterol and blood pressure goals in patients with arterial hypertension and dyslipidemia. The SNAPSHOT study [0.03%]
基于风险的低密度脂蛋白胆固醇和血压目标实现情况的现实世界特征研究——SNAPSHOT研究
Jose María Mostaza,Miquel Camafort Babkowksi,Soraya Sotto Rodriguez et al.
Jose María Mostaza et al.
Background: Arterial hypertension and dyslipidemia are two of the most relevant modifiable cardiovascular risk factors (CVRFs), and they often coexist. No recent studies specifically evaluating the achievement of LDL-C an...